MARKET

VECT

VECT

VectivBio Holding AG
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.880
-0.380
-7.22%
After Hours: 4.850 -0.03 -0.61% 16:11 01/21 EST
OPEN
5.24
PREV CLOSE
5.26
HIGH
5.24
LOW
4.810
VOLUME
34.21K
TURNOVER
--
52 WEEK HIGH
37.70
52 WEEK LOW
2.743
MARKET CAP
165.99M
P/E (TTM)
-2.7691
1D
5D
1M
3M
1Y
5Y
16 unloved stocks ripe for a rally: Bank of America
These IPO stocks look very oversold, argues Bank of America strategists.
Yahoo Finance · 3d ago
What Percentage Of VectivBio Holding AG (NASDAQ:VECT) Shares Do Insiders Own?
A look at the shareholders of VectivBio Holding AG ( NASDAQ:VECT ) can tell us which group is most powerful. Large...
Simply Wall St. · 01/05 15:14
BGFV, DWAC and EOLS among after-hours movers
Gainers: Arhaus (NASDAQ:ARHS) +6%. Radware (NASDAQ:RDWR) +5%. Liquidity Services (NASDAQ:LQDT) +5%. Digital World Acquisition (NASDAQ:DWAC) +3%. Big 5 Sporting Goods (NASDAQ:BGFV) +26%. Losers: Lucid Group (NASDAQ:LCID) -8%. Relmada Therapeutics (NASDAQ:RL...
Seekingalpha · 12/08/2021 22:49
VectivBio sees volatile trading on more than 10x average volume; shares briefly halted
Trading in VectivBio Holding (VECT +16.4%) has been on a rollercoaster ride today, as shares were down this morning but making a strong recovery in the afternoon. As of 313p
Seekingalpha · 12/08/2021 20:14
VectivBio Announces Third Quarter 2021 Business Update
-Pivotal STARS Program of Apraglutide in SBS-IF Progressing with Majority of Sites Activated and Screening; STARS Nutrition Interim Results Expected 1H 2022- -Expanded Rare Disease Pipeline with the Acquisition of CoMET Small Molecule Platform for Inherite...
GlobeNewswire · 11/10/2021 13:30
VectivBio to Present at the Credit Suisse 30th Annual Healthcare Conference
BASEL, Switzerland, Nov. 04, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced that Luca Santarell...
GlobeNewswire · 11/04/2021 11:15
BRIEF-Vectivbio Holding AG Announces Successful Opening Of US IND For Apraglutide For Acute Graft-Versus-Host Disease
reuters.com · 10/20/2021 11:18
VectivBio Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease
-FDA clears IND application for apraglutide for acute graft-versus-host disease -- Dosing of first patient expected in 1Q 2022 -- Interim data anticipated in 2H 2022 -- FDA previously granted orphan drug designation for apraglutide for the prevention of ac...
GlobeNewswire · 10/20/2021 11:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VECT. Analyze the recent business situations of VectivBio Holding AG through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average VECT stock price target is 25.50 with a high estimate of 31.00 and a low estimate of 19.00.
High31.00
Average25.50
Low19.00
Current 4.880
EPS
Actual
Estimate
-1.41-1.06-0.70-0.35
2019
2020
Institutional Holdings
Institutions: 25
Institutional Holdings: 23.72M
% Owned: 69.74%
Shares Outstanding: 34.01M
TypeInstitutionsShares
Increased
8
639.52K
New
2
131
Decreased
7
141.66K
Sold Out
2
61.63K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About VECT
VectivBio Holding AG is a holding company based in Switzerland. The Company trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.

Webull offers kinds of VectivBio Holding AG stock information, including NASDAQ:VECT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VECT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VECT stock methods without spending real money on the virtual paper trading platform.